Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Laureate Pharma and Iconic Therapeutics sign hI-con1 manufacturing agreement

May 15, 2006

VP-025 reduces retinal inflammation in experimental diabetic retinopathy

May 12, 2006

Senju reports positive preclinical data on the calpain inhibitor SNJ-1945

May 11, 2006

Otsuka launches Ozex Ophthalmic solution in Japan

May 11, 2006

Ube Industries and Santen to jointly develop ROCK inhibitor DE-104

May 11, 2006

MARINA reveals ranibizumab safety, quality of life impact in macular degeneration

May 11, 2006

Novel neuroprotective strategies in glaucoma therapeutics - Part II

May 10, 2006

New intraocular delivery system of antiproliferative agents reported

May 10, 2006

A novel multitargeted tyrosine kinase prodrug proves beneficial for CNV disorders

May 10, 2006

Opticin may contribute to the antiangiogenic properties of the vitreous humor

May 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...